Secondary Logo

Journal Logo

Articles by Céline Bouchard, MD

Lack of effect of intravaginal dehydroepiandrosterone (DHEA, prasterone) on the endometrium in postmenopausal women

Portman, David J.; Labrie, Fernand; Archer, David F.; More

Menopause. 22(12):1289-1295, December 2015.

Treatment of pain at sexual activity (dyspareunia) with intravaginal dehydroepiandrosterone (prasterone)

Archer, David F.; Labrie, Fernand; Bouchard, Céline; More

Menopause. 22(9):950-963, September 2015.

Serum steroid levels during 12-week intravaginal dehydroepiandrosterone administration

Labrie, Fernand; Archer, David; Bouchard, Céline; More

Menopause. 16(5):897-906, September-October 2009.

Intravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy

Labrie, Fernand; Archer, David; Bouchard, Céline; More

Menopause. 16(5):907-922, September-October 2009.

Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women

Labrie, Fernand; Archer, David; Bouchard, Céline; More

Menopause. 16(5):923-931, September-October 2009.

Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally

Bachmann, Gloria; Bouchard, Céline; Hoppe, Diana; More

Menopause. 16(4):719-727, July-August 2009.